Data / Drug companies / Dextromethorphan hbr, doxylamine succinate
Dextromethorphan hbr, doxylamine succinate: 12 companies and 18 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dextromethorphan hbr, doxylamine succinate is listed in the FDA National Drug Code Directory by 12 companies, with 18 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; liquid, and the newest product started marketing on February 25, 2026.
The request: Get every company that lists dextromethorphan hbr, doxylamine succinate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 18
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Tussin DM Nighttime, DG Health Tussin, HoneyWorks Plus Adult Nighttime Cough Syrup, Childrens Robitussin Honey Nighttime Cough DM, Nighttime Cough DM, Night Time Cough, Tussin DM Max Nighttime, Safetussin PM Nighttime Cough Relief
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hbr, doxylamine succinate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| CVS Woonsocket Prescription Center, Incorporated | 3 | solution; liquid | Over the counter monograph drugs | February 25, 2026 |
| Walgreen Company | 3 | solution; liquid | Over the counter monograph drugs | May 14, 2024 |
| Haleon US Holdings LLC | 2 | solution | Over the counter monograph drugs | May 27, 2019 |
| Raritan Pharmaceuticals Inc | 2 | solution | Over the counter monograph drugs | February 1, 2023 |
| Amazon.com Services LLC | 1 | solution | Over the counter monograph drugs | February 16, 2026 |
| American Sales Company | 1 | solution | Over the counter monograph drugs | October 22, 2018 |
| CVS Pharmacy | 1 | solution | Over the counter monograph drugs | June 25, 2018 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | solution | Over the counter monograph drugs | September 10, 2018 |
| Kramer Laboratories | 1 | liquid | Over the counter monograph drugs | July 28, 2023 |
| L.N.K. International, Inc. | 1 | solution | Over the counter monograph drugs | July 16, 2021 |
| Valu Merchandisers Company | 1 | liquid | Over the counter monograph drugs | January 31, 2018 |
| Wal-Mart Stores Inc | 1 | solution | Over the counter monograph drugs | August 15, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 14 | 77.8% |
| Liquid | 4 | 22.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 18 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antihistamine | 18 |
| Sigma-1 Agonist | 18 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 18 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.